Antiangiogenic agents for the treatment of glioblastoma

Author： Gerstner Elizabeth R Duda Dan G Tomaso Emmanuelle di Sorensen Greg Jain Rakesh K Batchelor Tracy T

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.12, 2007-12, pp. : 1895-1908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel chemotherapeutic agents for the treatment of glioblastoma multiforme

By Jendrossek Verena Belka Claus Bamberg Michael

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1899-1924

Informa Healthcare

Access to resources Recommend Favorite

Developmental antiangiogenic agents for the treatment of Non-Small Cell Lung Cancer (NSCLC)

By Blumenschein George

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1802-1811

Springer Publishing Company

Access to resources Recommend Favorite

Polyacetylenes Function as Anti-Angiogenic Agents

By Wu Li-Wha Chiang Yi-Ming Chuang Hsiao-Ching Wang Sheng-Yang Yang Ga-Wen Chen Ya-Huey Lai Ling-Ya Shyur Lie-Fen

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2112-2119

Springer Publishing Company

Access to resources Recommend Favorite

Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3069-3079

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombospondins as Anti-Angiogenic Therapeutic Agents

Current Pharmaceutical Design, Vol. 9, Iss. 7, 2003-03 ,pp. : 583-588

Bentham Science Publishers

Access to resources Recommend Favorite